|
Volumn 25, Issue 9, 2007, Pages 951-952
|
Funding crunch forces stem cell company to abandon therapies
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
EMBRYONIC STEM CELL;
FUNDING;
INVESTMENT;
NOTE;
PRIORITY JOURNAL;
SINGAPORE;
STEM CELL TRANSPLANTATION;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
INVESTMENTS;
ORGANIZATIONS;
STEM CELLS;
TISSUE THERAPY;
|
EID: 34948840846
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0907-951 Document Type: Note |
Times cited : (2)
|
References (0)
|